|Bid||1.0300 x 0|
|Ask||1.0400 x 0|
|Day's range||1.0300 - 1.0600|
|52-week range||0.9800 - 1.2000|
|Beta (3Y monthly)||0.60|
|PE ratio (TTM)||27.11|
|Forward dividend & yield||0.03 (2.36%)|
|1y target est||1.17|
Raffles Medical Group Ltd (SGX: BSL), DBS Group Holdings Ltd (SGX: D05), and SATS Ltd (SGX: S58) could be keepers in your portfolio.
Early last year, market research firm Frost and Sullivan predicted that the Asia-Pacific healthcare industry is going to grow at 11.1 percent in 2018 driven by an increasing adoption of technology, innovative healthcare access and delivery of care outside of traditional hospital settings. Concurrently, Singapore Exchange (SGX) also released a market update identifying the five largest healthcare companies listed on the local bourse in terms of market capitalisation.
Investors love companies which raise their dividends, and these three companies had increased theirs in the last fiscal year.
Once again, the quarterly earnings season is in full swing. As companies release their results, analysts are on the streets are also busying themselves with revising their estimates.
This simple number will help investors better understand three important parts of Raffles Medical Group Ltd's (SGX: BSL) business.
Raffles Medical Group Ltd’s (SGX: BSL) earnings have not grown spectacularly in the past but that could change. Here's why.
Raffles Medical Group Ltd (SGX: BSL) suffers a drop in earnings due to gestational losses from the opening of its new hospital in China.